Tag Archives: finance
The Case for Specialty Medicines: Is Industry Credible, or Culpable?
What’s so special about specialty? This was the question lurking below the surface in many of the presentations at a conference hosted by Pharm Exec’s sister organization, CBI, in Philadelphia last week. Now that the blockbuster era is fading under a wave of patent expirations, big pharma is pinning its hopes on the specialty category [...]

Fixing Biotech's Broken Business Model